Drawing for BIOFLUIDICA

USPTO serial 99783150

BIOFLUIDICA

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
BLACK, MILDRED ELIZABETH
Law office
TMO LAW OFFICE 121

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOFLUIDICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert Buchanan

Robert Buchanan TORREY PINES LAW GROUP, PC12636 High Bluff Drive, Suite 400San Diego, CA 92130United States

Goods and services

ClassDescriptionStatusFirst use
009Laboratory instruments for scientific and research use, namely, automated microfluidic sample processing modules for the isolation and enrichment of circulating tumor cells, fetal cells, and extracellular vesicles from biological samples; microfluidic chips and cartridges for laboratory use in processing and analyzing biological samples; laboratory consumables, namely, plastic labware adapted for use with automated laboratory instruments, namely, sample tubes and elution tubes; downloadable software for operating and controlling automated liquid-handling and microfluidic sample processing instruments and for acquiring and analyzing related data; all of the foregoing for scientific and research use and not for medical or veterinary purposesACTIVEJan 1, 2013
010Medical diagnostic instruments for clinical use, namely, automated microfluidic sample processing apparatus for the isolation and analysis of circulating tumor cells, extracellular vesicles and cell-free DNA from biological samples for use in in vitro diagnostic testing; microfluidic chips, cartridges and cassettes for medical diagnostic use with automated instruments for detecting biomarkers, namely, circulating tumor cells, fetal cells, extracellular vesicles and cell-free DNA; disposable medical diagnostic consumable sets for detecting biomarkers, namely, circulating tumor cells, fetal cells, extracellular vesicles and cell-free DNA, consisting primarily of fluidic cartridges, tubing sets and sample processing components for use with such instrumentsACTIVEJan 1, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 3, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2026DOCKASSIGNED TO EXAMINER—
Jul 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance